Heat Biologics Z Score
HTBX   USA Stock  USD 4.22 0.27 6.01% 
Heat Biologics Z Score  Heat Biologics Z Score 
Heat Biologics Z Score Analysis
Heat Biologics' ZScore is a simple linear, multifactor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..2018  2019  2020  2021 (projected)  
Current Assets  28.71 M  15.21 M  113.79 M  122.78 M 
Total Assets  37.76 M  25.96 M  124.19 M  134 M 
Z Score  =  Sum Of   5 Factors 
Current Heat Biologics Z Score  19.2 
Most of Heat Biologics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heat Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 
 
 
 

Heat Biologics Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Heat Biologics is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Z Score. Since Heat Biologics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Heat Biologics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Heat Biologics' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate ZScore one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. ZScore can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with ZScores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a socalled 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.
Compare to competition 
According to the company's disclosures, Heat Biologics has a Z Score of 19.2. This is 184.44% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The z score for all United States stocks is 120.18% lower than that of the firm.
Heat Biologics Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Heat Biologics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Heat Biologics could also be used in its relative valuation, which is a method of valuing Heat Biologics by comparing valuation metrics of similar companies.Heat Biologics is currently under evaluation in z score category among related companies.
Heat Biologics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Heat Biologics from analyzing Heat Biologics' financial statements. These drivers represent accounts that assess Heat Biologics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Heat Biologics' important valuation drivers and their relationship over time.
2016  2017  2018  2019  2020  2021 (projected)  
Average Assets  10.02 M  16 M  31.75 M  28.5 M  87.47 M  94.38 M  
Earnings Before Interest Taxes and Depreciation Amortization EBITDA  (11.89 M)  (12.52 M)  (16.48 M)  (19.7 M)  (25.62 M)  (26.3 M)  
Earnings Before Interest Taxes and Depreciation Amortization USD  (11.89 M)  (12.52 M)  (16.48 M)  (19.7 M)  (25.62 M)  (26.3 M)  
Earnings before Tax  (12.57 M)  (12.65 M)  (16.72 M)  (19.97 M)  (26.05 M)  (26.74 M)  
Average Equity  6.12 M  9.41 M  22.51 M  19.78 M  78.13 M  84.3 M  
Enterprise Value  14.67 M  9.34 M  1.73 M  6.85 M  99.4 M  107.25 M  
Free Cash Flow  (13.57 M)  (6.46 M)  (22.31 M)  (12.99 M)  (22.36 M)  (22.95 M)  
Invested Capital  (712.27 K)  (2.17 M)  8.2 M  8.56 M  109.88 M  118.55 M  
Invested Capital Average  1.05 M  1.35 M  3.07 M  9.05 M  63.4 M  68.4 M  
Market Capitalization  20.42 M  13.7 M  22.79 M  16.22 M  122.4 M  132.06 M  
Tangible Asset Value  8.9 M  18 M  35.57 M  24.5 M  122.74 M  132.43 M  
Working Capital  6.67 M  1.41 M  23.84 M  6.77 M  110.14 M  118.83 M 
Heat Biologics Fundamentals
Return On Equity  (33.90) %  
Return On Asset  (18.80) %  
Current Valuation  44.37 M  
Shares Outstanding  25.4 M  
Shares Owned by Insiders  4.09 %  
Shares Owned by Institutions  12.04 %  
Number of Shares Shorted  2.34 M  
Price to Earning  (1.29) X  
Price to Book  0.82 X  
Price to Sales  43.82 X  
Revenue  2.58 M  
Gross Profit  (9.99 M)  
EBITDA  (27.04 M)  
Net Income  (27.29 M)  
Cash and Equivalents  132.06 M  
Cash per Share  5.23 X  
Total Debt  1.76 M  
Debt to Equity  0.012 %  
Current Ratio  43.95 X  
Book Value Per Share  5.46 X  
Cash Flow from Operations  (21.09 M)  
Short Ratio  6.47 X  
Earnings Per Share  (1.36) X  
Number of Employees  39  
Beta  0.28  
Market Capitalization  113.27 M  
Total Asset  11.75 M  
Retained Earnings  (107.35 M)  
Working Capital  6.77 M  
Current Asset  11.27 M  
Current Liabilities  4.5 M  
Z Score  19.2 
About Heat Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Heat Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Heat Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Heat Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patients immune system against cancer through Tcell activation and expansion. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina. Heat Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.
Heat Biologics Investors Sentiment
The influence of Heat Biologics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decisionmaking process regarding taking a position in Heat Biologics. The overall investor sentiment generally increases the direction of a stock movement in a oneyear investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.Heat Biologics Implied Volatility  167.8 
Heat Biologics' implied volatility exposes the market's sentiment of Heat Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Heat Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Heat Biologics stock will not fluctuate a lot when Heat Biologics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Heat Biologics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Heat Biologics' short interest history, or implied volatility extrapolated from Heat Biologics options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Heat Biologics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Please check Heat Biologics Piotroski F Score and Heat Biologics Valuation analysis. Note that the Heat Biologics information on this page should be used as a complementary analysis to other Heat Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Heat Biologics Stock analysis
When running Heat Biologics price analysis, check to measure Heat Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heat Biologics is operating at the current time. Most of Heat Biologics' value examination focuses on studying past and present price action to predict the probability of Heat Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Heat Biologics' price. Additionally, you may evaluate how the addition of Heat Biologics to your portfolios can decrease your overall portfolio volatility.
Commodity Channel IndexUse Commodity Channel Index to analyze current equity momentum  Go  
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios  Go  
Portfolio File ImportQuickly import all of your thirdparty portfolios from your local drive in csv format  Go  
Equity SearchSearch for activelly traded equities including funds and ETFs from over 30 global markets  Go  
Financial WidgetsEasily integrated Macroaxis content with over 30 different plugandplay financial widgets  Go  
RiskReturn AnalysisView associations between returns expected from investment and the risk you assume  Go 
The market value of Heat Biologics is measured differently than its book value, which is the value of Heat Biologics that is recorded on the company's balance sheet. Investors also form their own opinion of Heat Biologics' value that differs from its market value or its book value, called intrinsic value, which is Heat Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heat Biologics' market value can be influenced by many factors that don't directly affect Heat Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heat Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Heat Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heat Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.